Kaftrio, sold as Trikafta in the U.S., continues to thin mucus and to reduce the number of harmful bacteria…
Articles by Margarida Maia, PhD
Body composition assessments, particularly fat mass and fat-free mass, may be more informative than body mass index (BMI) for monitoring…
First Wave BioPharma has finished dosing in its Phase 2 clinical study, SPAN, in which a new adrulipase formulation…
Kaftrio improved lung function for up to 2.5 years in cystic fibrosis (CF) patients with advanced disease who had…
Nearly half of patients with cystic fibrosis (CF) due to a G542X mutation saw their lung function improve with…
Taking Kaftrio, a combination of elexacaftor, tezacaftor, and ivacaftor sold as Trikafta in the U.S., for up to 24…
Children with cystic fibrosis (CF) who also have symptoms of attention-deficit/hyperactivity disorder (ADHD) may experience worse lung function,…
Vertex Pharmaceuticals has received a positive opinion from an arm of the European Medicines Agency on expanding the use…
Communities of fungi in the airways can be more diverse in cystic fibrosis (CF) patients with better lung function and…
Overactive T2 inflammation, a type of immune response linked to asthma, may be associated with worse symptoms of cystic…